Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Do all patients with HER2-positive gastric/GEJ cancer benefit from trastuzumab?
- Authors
- Yi, JH[Yi, Jun Ho]; Kang, JH[Kang, Jung Hun]; Hwang, IG[Hwang, In Gyu]; Ahn, HK[Ahn, Hee Kyung]; Lee, S[Lee, Soonil]; Lim, DH[Lim, Do Hyoung]; Won, YW[Won, Young-Woong]; Ji, JH[Ji, Jun Ho]; Kim, HS[Kim, Hyo Song]; Rha, SY[Rha, Sun Young]; Oh, SY[Oh, Sung Yong]; Lee, KE[Lee, Kyung Eun]; Lim, T[Lim, Taekyu]; Kim, ST[Kim, Seung Tae]; Lee, J[Lee, Jeeyun]; Park, JO[Park, Joon Oh]; Park, YS[Park, Young Suk]; Lim, HY[Lim, Ho Yeong]; Kang, WK[Kang, Won Ki]; Park, SH[Park, Se Hoon]
- Issue Date
- 20-Jan-2015
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.33, no.3
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 33
- Number
- 3
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.